Library Subscription: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems

Published 6 issues per year

ISSN Print: 0743-4863

ISSN Online: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Cyclodextrin Derivatives in Pharmaceutics

Volume 12, Issue 4, 1995, pp. 311-337
DOI: 10.1615/CritRevTherDrugCarrierSyst.v12.i4.20
Get accessGet access

ABSTRACT

The current cyclodextrin (CD) literature is reviewed concerning synthesis, characterization, and pharmaceutical relevant applications of CD derivatives. Although natural CDs have been used extensively to improve pharmaceutical properties, the effects of chemically modified CDs on the solubility, dissolution rate, and stability of drugs are overproportional. Concerning the parenteral application, the major interest is focussed on highly water-soluble, randomly substituted hydroxyalkyl derivatives of β- and γ-CD such as 2-hydroxypropyl-β-cyclodextrin (2-HP-β-CD). Although the heptakis-(2,6-di-O-methyl)-β-cyclodextrin is applied in the pharmaceutical field, 2-HP-β-CD is predestined as a parenteral drug carrier owing to its weak hemolytic activity and intrinsically amorphous character. A minimal average degree of substitution is especially preferred when 2-HP-β-CD is used as solubilizer of pharmaceuticals for the use in parenteral applications. The influence of the type, degree, and pattern of substitution of the CDs, as well as substituent effects of the guest molecule is elucidated.

CITED BY
  1. Gorman Eric M., Padden Brian E., Munson Eric J., Stability: Physical and Chemical, in Pharmaceutical Sciences Encyclopedia, 2010. Crossref

  2. Bilensoy Erem, Hincal A. Atilla, Cyclodextrin-Based Nanomaterials in Pharmaceutical Field, in Pharmaceutical Sciences Encyclopedia, 2010. Crossref

  3. Li Ping, Zhao Luwei, Developing early formulations: Practice and perspective, International Journal of Pharmaceutics, 341, 1-2, 2007. Crossref

  4. Mannila Anne, Morizzi Julia, Nguyen Thuy Tien, Charman Susan A., Mcintosh Michelle P., Shackleford David M., Probing a Potential In Vivo Drug–Excipient Interaction: Temporal Effects of a Modified β-Cyclodextrin on the Intravenous Pharmacokinetics of a Model High-Affinity Drug Ligand, Journal of Pharmaceutical Sciences, 101, 9, 2012. Crossref

  5. Davis Mark E., Brewster Marcus E., Cyclodextrin-based pharmaceutics: past, present and future, Nature Reviews Drug Discovery, 3, 12, 2004. Crossref

  6. Charoensakdi Ratiya, Iizuka Masaru, Ito Kazuo, Rimphanitchayakit Vichien, Limpaseni Tipaporn, A recombinant cyclodextrin glycosyltransferase cloned from Paenibacillus sp. strain RB01 showed improved catalytic activity in coupling reaction between cyclodextrins and disaccharides, Journal of Inclusion Phenomena and Macrocyclic Chemistry, 57, 1-4, 2007. Crossref

  7. Bilensoy Erem, Doğan Lale, Şen Murat, Hıncal Atilla, Complexation behavior of antiestrogen drug tamoxifen citrate with natural and modified β-cyclodextrins, Journal of Inclusion Phenomena and Macrocyclic Chemistry, 57, 1-4, 2007. Crossref

  8. Kono Hiroyuki, Onishi Kenta, Nakamura Taichi, Characterization and bisphenol A adsorption capacity of β-cyclodextrin–carboxymethylcellulose-based hydrogels, Carbohydrate Polymers, 98, 1, 2013. Crossref

  9. Hirayama Fumitoshi, Mieda Shiuhei, Miyamoto Yuji, Arima Hidetoshi, Uekama Kaneto, Heptakis(2,6‐di‐O‐methyl‐3‐O‐acetyl)‐β‐cyclodextrin: A Water‐Soluble cyclodextrin derivative with low hemolytic activity, Journal of Pharmaceutical Sciences, 88, 10, 1999. Crossref

  10. Irie Tetsumi, Uekama Kaneto, Pharmaceutical Applications of Cyclodextrins. III. Toxicological Issues and Safety Evaluation, Journal of Pharmaceutical Sciences, 86, 2, 1997. Crossref

  11. Lysik Melanie A., Wu-Pong Susanna, Innovations in Oligonucleotide Drug Delivery, Journal of Pharmaceutical Sciences, 92, 8, 2003. Crossref

  12. Mura Paola, Analytical techniques for characterization of cyclodextrin complexes in aqueous solution: A review, Journal of Pharmaceutical and Biomedical Analysis, 101, 2014. Crossref

  13. Xu Caibing, Tang Yalan, Hu Wenjing, Tian Rui, Jia Yuntao, Deng Ping, Zhang Liangke, Investigation of inclusion complex of honokiol with sulfobutyl ether-β-cyclodextrin, Carbohydrate Polymers, 113, 2014. Crossref

  14. Němcová Irena, Nesměrák Karel, Kafková Božena, Sejbal Jan, Physicochemical Properties of 9-(Alkylsulfanyl)- and 9-(Arylsulfanyl)acridine Derivatives and Their Interaction with (2-Hydroxypropyl)cyclodextrins, Collection of Czechoslovak Chemical Communications, 71, 2, 2006. Crossref

  15. Brock William J., Peroral Toxicity, in General and Applied Toxicology, 2009. Crossref

  16. Memisoglu-Bilensoy Erem, Doǧan A Lale, Hincal A Atilla, Cytotoxic evaluation of injectable cyclodextrin nanoparticles, Journal of Pharmacy and Pharmacology, 58, 5, 2010. Crossref

  17. Kayser Oliver, Kiderlen Albrecht F, Delivery strategies for antiparasitics, Expert Opinion on Investigational Drugs, 12, 2, 2003. Crossref

  18. Luong John H.T, Nguyen A.L, Achiral selectivity in cyclodextrin-modified capillary electrophoresis, Journal of Chromatography A, 792, 1-2, 1997. Crossref

  19. Tonglairoum Prasopchai, Ngawhirunpat Tanasait, Rojanarata Theerasak, Kaomongkolgit Ruchadaporn, Opanasopit Praneet, Fast-Acting Clotrimazole Composited PVP/HPβCD Nanofibers for Oral Candidiasis Application, Pharmaceutical Research, 31, 8, 2014. Crossref

  20. Zaki S, Ticehurst KE, Miyaki Y, Clinical evaluation of Alfaxan-CD® as an intravenous anaesthetic in young cats, Australian Veterinary Journal, 87, 3, 2009. Crossref

  21. LU Chang-Sheng, REN Xiao-Ming, HU Chuan-Jiang, ZHU Hui-Zhen, MENG Qing-Jin, The Inclusion Compound of a New Ionizable Derivative of .BETA.-Cyclodextrin with Ferrocenium Drug., Chemical and Pharmaceutical Bulletin, 49, 7, 2001. Crossref

  22. Schaschke Norbert, Assfalg-Machleidt Irmgard, Machleidt Werner, Laßleben Thomas, Sommerhoff Christian P, Moroder Luis, β-Cyclodextrin/epoxysuccinyl peptide conjugates: a new drug targeting system for tumor cells, Bioorganic & Medicinal Chemistry Letters, 10, 7, 2000. Crossref

  23. Kamada Makoto, Hirayama Fumitoshi, Udo Koichi, Yano Hideki, Arima Hidetoshi, Uekama Kaneto, Cyclodextrin conjugate-based controlled release system: repeated- and prolonged-releases of ketoprofen after oral administration in rats, Journal of Controlled Release, 82, 2-3, 2002. Crossref

  24. Gonzalo-Lumbreras R., García-Miguens M.A., Izquierdo-Hornillos R., HPLC method development for testosterone propionate and cipionate in oil-based injectables, Journal of Pharmaceutical and Biomedical Analysis, 38, 4, 2005. Crossref

  25. Tokihiro Keiichi, Arima Hidetoshi, Tajiri Shinichirou, Irie Tetsumi, Hirayama Fumitoshi, Uekama Kaneto, Improvement of Subcutaneous Bioavailability of Insulin by Sulphobutyl Ether β-Cyclodextrin in Rats, Journal of Pharmacy and Pharmacology, 52, 8, 2010. Crossref

  26. Wu Zimei, Tucker Ian G., Razzak Majid, Yang Lin, McSporran Keith, Medlicott Natalie J., Absorption and tissue tolerance of ricobendazole in the presence of hydroxypropyl-β-cyclodextrin following subcutaneous injection in sheep, International Journal of Pharmaceutics, 397, 1-2, 2010. Crossref

  27. Arima Hidetoshi, Motoyama Keiichi, Irie Tetsumi, Recent Findings on Safety Profiles of Cyclodextrins, Cyclodextrin Conjugates, and Polypseudorotaxanes, in Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine, 2011. Crossref

  28. Tonglairoum Prasopchai, Ngawhirunpat Tanasait, Rojanarata Theerasak, Panomsuk Suwanee, Kaomongkolgit Ruchadaporn, Opanasopit Praneet, Fabrication of mucoadhesive chitosan coated polyvinylpyrrolidone/cyclodextrin/clotrimazole sandwich patches for oral candidiasis, Carbohydrate Polymers, 132, 2015. Crossref

  29. Bibby David C., Davies Nigel M., Tucker Ian G., Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems, International Journal of Pharmaceutics, 197, 1-2, 2000. Crossref

  30. Tiemessen Harry, van Hoogevest Peter, Leigh Mathew L.S., Characteristics of a novel phospholipid-based depot injectable technology for poorly water-soluble drugs, European Journal of Pharmaceutics and Biopharmaceutics, 58, 3, 2004. Crossref

  31. Karande Pankaj, Mitragotri Samir, Enhancement of transdermal drug delivery via synergistic action of chemicals, Biochimica et Biophysica Acta (BBA) - Biomembranes, 1788, 11, 2009. Crossref

  32. Burhan N., Sapundzhiev Ts., Beschkov V., Mathematical modelling of cyclodextrin-glucanotransferase production by batch cultivation, Biochemical Engineering Journal, 24, 1, 2005. Crossref

  33. Kiss T., Fenyvesi F., Bácskay I., Váradi J., Fenyvesi É., Iványi R., Szente L., Tósaki Á., Vecsernyés M., Evaluation of the cytotoxicity of β-cyclodextrin derivatives: Evidence for the role of cholesterol extraction, European Journal of Pharmaceutical Sciences, 40, 4, 2010. Crossref

  34. Chow Shing Fung, Wan Ka Yee, Cheng Kwok Kin, Wong Ka Wai, Sun Changquan Calvin, Baum Larry, Chow Albert Hee Lum, Development of highly stabilized curcumin nanoparticles by flash nanoprecipitation and lyophilization, European Journal of Pharmaceutics and Biopharmaceutics, 94, 2015. Crossref

  35. Rodriguez-Aller Marta, Guinchard Sylvie, Guillarme Davy, Pupier Marion, Jeannerat Damien, Rivara-Minten Elisabeth, Veuthey Jean-Luc, Gurny Robert, New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular tolerance, European Journal of Pharmaceutics and Biopharmaceutics, 95, 2015. Crossref

  36. van der Maarel Marc J.E.C, van der Veen Bart, Uitdehaag Joost C.M, Leemhuis Hans, Dijkhuizen L, Properties and applications of starch-converting enzymes of the α-amylase family, Journal of Biotechnology, 94, 2, 2002. Crossref

  37. Wang Feng, Du Guo-Cheng, Li Yin, Chen Jian, Effects of dissolved oxygen concentration and two-stage oxygen supply strategy on the production of γ-CGTase by Bacillus macorous, Process Biochemistry, 40, 11, 2005. Crossref

  38. Ringard-Lefebvre Catherine, Bochot Amélie, Memisoğlu Erem, Charon Daniel, Duchêne Dominique, Baszkin Adam, Effect of spread amphiphilic β-cyclodextrins on interfacial properties of the oil/water system, Colloids and Surfaces B: Biointerfaces, 25, 2, 2002. Crossref

  39. van der Veen Bart A, Uitdehaag Joost C.M, Dijkstra Bauke W, Dijkhuizen Lubbert, Engineering of cyclodextrin glycosyltransferase reaction and product specificity, Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1543, 2, 2000. Crossref

  40. Mura Paola, Analytical techniques for characterization of cyclodextrin complexes in the solid state: A review, Journal of Pharmaceutical and Biomedical Analysis, 113, 2015. Crossref

  41. MacKenzie Craig R, Fawcett J.Paul, Boulton David W, Tucker Ian G, Formulation and evaluation of a propanidid hydroxypropyl-β-cyclodextrin solution for intravenous anaesthesia, International Journal of Pharmaceutics, 159, 2, 1997. Crossref

  42. Bandi Nagesh, Wei William, Roberts Christopher B., Kotra Lakshmi P., Kompella Uday B., Preparation of budesonide– and indomethacin–hydroxypropyl-β-cyclodextrin (HPBCD) complexes using a single-step, organic-solvent-free supercritical fluid process, European Journal of Pharmaceutical Sciences, 23, 2, 2004. Crossref

  43. Wang Feng, Du Guocheng, Li Yin, Chen Jian, Regulation of CCR in the γ-CGTase production from Bacillus macorous by the specific cell growth rate control, Enzyme and Microbial Technology, 39, 6, 2006. Crossref

  44. Nagase Y., Hirata M., Wada K., Arima H., Hirayama F., Irie T., Kikuchi M., Uekama K., Improvement of some pharmaceutical properties of DY-9760e by sulfobutyl ether β-cyclodextrin, International Journal of Pharmaceutics, 229, 1-2, 2001. Crossref

  45. Bowdle Andrew, Hines Roberta, Introduction: Pharmacology update 2002, Seminars in Anesthesia, Perioperative Medicine and Pain, 21, 4, 2002. Crossref

  46. Yavuz Burçin, Bilensoy Erem, Vural İmran, Şumnu Murat, Alternative oral exemestane formulation: Improved dissolution and permeation, International Journal of Pharmaceutics, 398, 1-2, 2010. Crossref

  47. Schaschke N., Musiol H.-J., Assfalg-Machleidt I., Machleidt W., Rudolph-Böhner S., Moroder L., Cyclodextrins as templates for the presentation of protease inhibitors, FEBS Letters, 391, 3, 1996. Crossref

  48. Calabrò M.L, Tommasini S, Donato P, Raneri D, Stancanelli R, Ficarra P, Ficarra R, Costa C, Catania S, Rustichelli C, Gamberini G, Effects of α- and β-cyclodextrin complexation on the physico-chemical properties and antioxidant activity of some 3-hydroxyflavones, Journal of Pharmaceutical and Biomedical Analysis, 35, 2, 2004. Crossref

  49. Marttin E., Verhoef J. C., Merkus F. W.H.M., Efficacy, Safety and Mechanism of Cyclodextrins as Absorption Enhancers in Nasal Delivery of Peptide and Protein Drugs, Journal of Drug Targeting, 6, 1, 1998. Crossref

  50. Larsen Kim L, Zimmermann Wolfgang, Analysis and characterisation of cyclodextrins and their inclusion complexes by affinity capillary electrophoresis, Journal of Chromatography A, 836, 1, 1999. Crossref

  51. Schaschke Norbert, Musiol Hans-Jürgen, Assfalg-Machleidt Irmgard, Machleidt Werner, Moroder Luis, Oligopresentation of protease inhibitors with β-cyclodextrin as template, Bioorganic & Medicinal Chemistry Letters, 7, 19, 1997. Crossref

  52. Wang Lu-Lu, Zheng Wen-Sheng, Chen Shao-Hua, Han Yan-Xing, Jiang Jian-Dong, Development of rectal delivered thermo-reversible gelling film encapsulating a 5-fluorouracil hydroxypropyl-β-cyclodextrin complex, Carbohydrate Polymers, 137, 2016. Crossref

  53. Deng Yinghui, Pang Yanhua, Guo Yafei, Ren Yufeng, Wang Fen, Liao Xiali, Yang Bo, Host-guest inclusion systems of daidzein with 2-hydroxypropyl-β-cyclodextrin (HP-β-CD) and sulfobutyl ether-β-cyclodextrin (SBE-β-CD): Preparation, binding behaviors and water solubility, Journal of Molecular Structure, 1118, 2016. Crossref

  54. Nagase Y., Hirata M., Arima H., Tajiri S., Nishimoto Y., Hirayama F., Irie T., Uekama K., Protective Effect of Sulfobutyl Ether β‐Cyclodextrin on DY‐9760e‐Induced Hemolysis In Vitro, Journal of Pharmaceutical Sciences, 91, 11, 2002. Crossref

  55. Basic Concepts in Drug Targeting, in Bio-Targets and Drug Delivery Approaches, 2016. Crossref

  56. Gundogdu Evren, Koksal Cinel, Karasulu Ercument, Comparison of cefpodoxime proxetil release and antimicrobial activity from tablet formulations: Complexation with hydroxypropyl-β-cyclodextrin in the presence of water soluble polymer, Drug Development and Industrial Pharmacy, 38, 6, 2012. Crossref

  57. Nagase Yukihiko, Arima Hidetoshi, Wada Koki, Sugawara Tadaki, Satoh Hiroshi, Hirayama Fumitoshi, Uekama Kaneto, Inhibitory Effect of Sulfobutyl Ether β‐cyclodextrin on DY‐9760e‐Induced Cellular Damage: In vitro and in vivo Studies, Journal of Pharmaceutical Sciences, 92, 12, 2003. Crossref

  58. Lockhart Jacob N., Beezer Dain B., Stevens David M., Spears Benjamin R., Harth Eva, One-pot polyglycidol nanogels via liposome master templates for dual drug delivery, Journal of Controlled Release, 244, 2016. Crossref

  59. Bilensoy Erem, Hincal A Atilla, Recent advances and future directions in amphiphilic cyclodextrin nanoparticles, Expert Opinion on Drug Delivery, 6, 11, 2009. Crossref

  60. Malanga Milo, Szemán Julianna, Fenyvesi Éva, Puskás István, Csabai Katalin, Gyémánt Gyöngyi, Fenyvesi Ferenc, Szente Lajos, “Back to the Future”: A New Look at Hydroxypropyl Beta-Cyclodextrins, Journal of Pharmaceutical Sciences, 105, 9, 2016. Crossref

  61. (Tony) Tong Wei-Qin, Wen Hong, Preformulation Aspects of Insoluble Compounds, in Water-Insoluble Drug Formulation, Second Edition, 2008. Crossref

  62. APPENDIX E: COMMON VEHICLES FOR THE NONCLINICAL EVALUATION OF THERAPEUTIC AGENTS, in Drug Safety Evaluation, 2017. Crossref

  63. Ahsan Saad M., Rao Ch. Mohan, Condition responsive nanoparticles for managing infection and inflammation in keratitis, Nanoscale, 9, 28, 2017. Crossref

  64. Gad Shayne C., Cassidy Crystal D., Aubert Nicolas, Spainhour Bart, Robbe Heide, Nonclinical Vehicle Use in Studies by Multiple Routes in Multiple Species, International Journal of Toxicology, 25, 6, 2006. Crossref

  65. Gorecki P., Rainsford K.D., Taneja P., Bulsara Y., Pearson D., Saund D., Ahmed B., Dietrich T., Submucosal Diclofenac for Acute Postoperative Pain in Third Molar Surgery: A Randomized, Controlled Clinical Trial, Journal of Dental Research, 97, 4, 2018. Crossref

  66. Gad Shayne Cox, Spainhour Charles B., Shoemake Catherine, Pallman Danielle R. Stackhouse, Stricker-Krongrad Alain, Downing Philip A., Seals Richard E., Eagle Leslie Anne, Polhamus Kara, Daly Jennifer, Tolerable Levels of Nonclinical Vehicles and Formulations Used in Studies by Multiple Routes in Multiple Species With Notes on Methods to Improve Utility, International Journal of Toxicology, 35, 2, 2016. Crossref

  67. Sonoda Yoh, Hirayama Fumitoshi, Arima Hidetoshi, Uekama Kaneto, Effects of 2-Hydroxypropyl-b-cyclodextrin on Polymorphic Transition of Chlorpropamide in Various Conditions: Temperature, Humidity and Moulding Pressure, Journal Of Inclusion Phenomena, 50, 1-2, 2004. Crossref

  68. Sonoda Yoh, Hirayama Fumitoshi, Arima Hidetoshi, Uekama Kaneto, Effects of 2-Hydroxypropyl-b-cyclodextrin on Polymorphic Transition of Chlorpropamide in Various Conditions: Temperature, Humidity and Moulding Pressure, Journal of Inclusion Phenomena and Macrocyclic Chemistry, 50, 1-2, 2004. Crossref

  69. Saka Raju, Sathe Priyadarshini, Khan Wahid, Dubey Sachin, Preclinical Formulation Assessment ofNCEs, in Innovative Dosage Forms, 2019. Crossref

  70. Quax Wim J., Bacterial Enzymes, in The Prokaryotes, 2006. Crossref

  71. Haidekker Mark A., Nipper Matthew, Mustafic Adnan, Lichlyter Darcy, Dakanali Marianna, Theodorakis Emmanuel A., Dyes with Segmental Mobility: Molecular Rotors, in Advanced Fluorescence Reporters in Chemistry and Biology I, 8, 2010. Crossref

  72. Quax Wim J., Bacterial Enzymes, in The Prokaryotes, 2013. Crossref

  73. Cravotto Giancarlo, Palmisano Giovanni, Panza Luigi, Tagliapietra Silvia, Synthesis of Selectively Permodified γ–Cyclodextrins. A New Set of Chiral Stationary Phases in Capillary GC, Journal of Carbohydrate Chemistry, 19, 9, 2000. Crossref

  74. Tian Bingren, Liu Yumei, Liu Jiayue, Cyclodextrin as a magic switch in covalent and non-covalent anticancer drug release systems, Carbohydrate Polymers, 242, 2020. Crossref

  75. Adeoye Oluwatomide, Bártolo Inês, Conceição Jaime, da Silva Andreia Bento, Duarte Noélia, Francisco Ana Paula, Taveira Nuno, Cabral-Marques Helena, Pyromellitic dianhydride crosslinked soluble cyclodextrin polymers: Synthesis, lopinavir release from sub-micron sized particles and anti-HIV-1 activity, International Journal of Pharmaceutics, 583, 2020. Crossref

  76. Mura Paola, Advantages of the combined use of cyclodextrins and nanocarriers in drug delivery: A review, International Journal of Pharmaceutics, 579, 2020. Crossref

  77. Morin-Crini Nadia, Fourmentin Sophie, Fenyvesi Éva, Lichtfouse Eric, Torri Giangiacomo, Fourmentin Marc, Crini Grégorio, History of Cyclodextrins, in The History of Cyclodextrins, 52, 2020. Crossref

  78. Wakao Masahiro, Fukase Koichi, Kusumoto Shoichi, Chemical Synthesis of Cyclodextrins by Using Intramolecular Glycosylation, The Journal of Organic Chemistry, 67, 23, 2002. Crossref

  79. Stella Valentino J., He Quanren, Cyclodextrins, Toxicologic Pathology, 36, 1, 2008. Crossref

  80. Griebenow Kai, Laureano Yanira Díaz, Santos Angélica M., Clemente Ileana Montañez, Rodríguez Luiz, Vidal Michael W., Barletta Gabriel, Improved Enzyme Activity and Enantioselectivity in Organic Solvents by Methyl-β-cyclodextrin, Journal of the American Chemical Society, 121, 36, 1999. Crossref

  81. Sadeghnia Hamid Reza, Vahdati Hassani Faezeh, Sadeghian Hamid, Miandehi Maryam, Hadizadeh Farzin, Karimi Gholamreza, Evaluation of in vitro toxicity of peptide (N-acetyl-Leu-Gly-Leu-COOH)-substituted-β-cyclodextrin derivative, a novel drug carrier, in PC-12 cells, DARU Journal of Pharmaceutical Sciences, 21, 1, 2013. Crossref

  82. Tong Xinchun S., Wang Junying, Zheng Song, Pivnichny James V., Griffin Patrick R., Shen Xiaolan, Donnelly Marcie, Vakerich Ken, Nunes Chris, Fenyk-Melody Judy, Effect of Signal Interference from Dosing Excipients on Pharmacokinetic Screening of Drug Candidates by Liquid Chromatography/Mass Spectrometry, Analytical Chemistry, 74, 24, 2002. Crossref

  83. Schaschke Norbert, Fiori Stella, Weyher Elisabeth, Escrieut Chantal, Fourmy Daniel, Müller Gerhard, Moroder Luis, Cyclodextrin as Carrier of Peptide Hormones. Conformational and Biological Properties of β-Cyclodextrin/Gastrin Constructs, Journal of the American Chemical Society, 120, 28, 1998. Crossref

  84. Hurley Jerome C., Volz Stephanie A., Johnston John J., Stabilization of the Avicide 3-Chloro-p-toluidine as the β-Cyclodextrin Adduct, Journal of Agricultural and Food Chemistry, 47, 7, 1999. Crossref

  85. Demirci Sahin, Khiev Dawin, Can Mehmet, Sahiner Mehtap, Biswal Manas R., Ayyala Ramesh S., Sahiner Nurettin, Chemically Cross-Linked Poly(β-Cyclodextrin) Particles as Promising Drug Delivery Materials, ACS Applied Polymer Materials, 3, 12, 2021. Crossref

  86. Calleja Patricia, Huarte Judit, Agüeros Maite, Ruiz-Gatón Luisa, Espuelas Socorro, Irache Juan M, Molecular buckets: cyclodextrins for oral cancer therapy, Therapeutic Delivery, 3, 1, 2012. Crossref

  87. Crini Grégorio, Review: A History of Cyclodextrins, Chemical Reviews, 114, 21, 2014. Crossref

  88. Yildiz Zehra I., Kilic Mehmet E., Durgun Engin, Uyar Tamer, Molecular Encapsulation of Cinnamaldehyde within Cyclodextrin Inclusion Complex Electrospun Nanofibers: Fast-Dissolution, Enhanced Water Solubility, High Temperature Stability, and Antibacterial Activity of Cinnamaldehyde, Journal of Agricultural and Food Chemistry, 67, 40, 2019. Crossref

  89. Bordusa Frank, Proteases in Organic Synthesis, Chemical Reviews, 102, 12, 2002. Crossref

  90. Arima Hidetoshi, Higashi Taishi, Motoyama Keiichi, Improvement of the bitter taste of drugs by complexation with cyclodextrins: applications, evaluations and mechanisms, Therapeutic Delivery, 3, 5, 2012. Crossref

  91. Khan Abdul Rauf, Forgo Peter, Stine Keith J., D'Souza Valerian T., Methods for Selective Modifications of Cyclodextrins, Chemical Reviews, 98, 5, 1998. Crossref

  92. Kihara Fumihiro, Arima Hidetoshi, Tsutsumi Toshihito, Hirayama Fumitoshi, Uekama Kaneto, Effects of Structure of Polyamidoamine Dendrimer on Gene Transfer Efficiency of the Dendrimer Conjugate with α-Cyclodextrin, Bioconjugate Chemistry, 13, 6, 2002. Crossref

  93. Uekama Kaneto, Hirayama Fumitoshi, Irie Tetsumi, Cyclodextrin Drug Carrier Systems, Chemical Reviews, 98, 5, 1998. Crossref

  94. de Oliveira Vanessa E., Almeida Eduardo W. C., Castro Harlem V., Edwards Howell G. M., Dos Santos Hélio F., de Oliveira Luiz Fernando C., Carotenoids and β-Cyclodextrin Inclusion Complexes: Raman Spectroscopy and Theoretical Investigation, The Journal of Physical Chemistry A, 115, 30, 2011. Crossref

  95. Harries Daniel, Rau Donald C., Parsegian V. Adrian, Solutes Probe Hydration in Specific Association of Cyclodextrin and Adamantane, Journal of the American Chemical Society, 127, 7, 2005. Crossref

  96. Kihara Fumihiro, Arima Hidetoshi, Tsutsumi Toshihito, Hirayama Fumitoshi, Uekama Kaneto, In Vitro and In Vivo Gene Transfer by an Optimized α-Cyclodextrin Conjugate with Polyamidoamine Dendrimer, Bioconjugate Chemistry, 14, 2, 2003. Crossref

  97. Sur Surojit, Fries Anja C., Kinzler Kenneth W., Zhou Shibin, Vogelstein Bert, Remote loading of preencapsulated drugs into stealth liposomes, Proceedings of the National Academy of Sciences, 111, 6, 2014. Crossref

  98. Locke Darren, Koreen Irina V., Liu Jade Yu, Harris Andrew L., Reversible Pore Block of Connexin Channels by Cyclodextrins, Journal of Biological Chemistry, 279, 22, 2004. Crossref

  99. Odeh Fadwa, Adaileh Fedaa, Alshaer Walhan, Nsairat Hamdi, Alqudah Dana A., Jaber Areej M., Al Bawab Abeer, Synthesis of Mono-Amino Substituted γ-CD: Host–Guest Complexation and In Vitro Cytotoxicity Investigation, Molecules, 27, 5, 2022. Crossref

  100. Chopra Hitesh, Verma Ravinder , Kaushik Sakshi , Parashar Jatin , Madan Kumud , Bano Afsareen , Bhardwaj Rashmi , Pandey Parijat , Kumari Beena , Purohit Deepika , Kumar Manish , Bhatia Saurabh , Rahman Md. Habibur , Mittal Vineet, Singh Inderbir , Kaushik Deepak, Cyclodextrin-Based Arsenal for Anti-Cancer Treatments , Critical Reviews™ in Therapeutic Drug Carrier Systems, 40, 2, 2023. Crossref

Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain